深度报告-20230520-华创证券-医疗器械行业深度研究报告_华创医疗器械求索系列5_电生理行业国产替代机会分析_28页_3mb.pdf
2009 1210 2023 05 20 5 1+2+2022 10 EasyStars 1/2 2023 5 2022 12 FireMagicTrueForce NMPA 1 2 3 S0360520110002 S0360520110004%()105 0.01()16,717.95 1.77()11,907.89 1.66%1M 6M 12M-5.3%-9.7%0.5%-0.3%-13.8%1.4%3 2022-08-23 2 2022-07-04-12%-4%5%14%22/05 22/07 22/10 22/12 23/03 23/052022-05-192023-05-19 300 2009 1210+2022 10 EasyStars 2023 5 2022 12 FireMagicTrueForce NMPA 2009 1210 3.5.5.6.7.9.10.10+.11.12.13.14.14.15.16.17.17.18.19.19.19.20.21.21.23.25 2009 1210 4 1.5 2.5 3.6 4.7 5 2028 123.7 6 2021.7 7.8 8.8 9.8 10.9 11.9 12 2024 211.9 13 2019/2020/.9 14.10 15.10 16+.12 17.13 18.13 19.14 20.15 21.16 22.16 23.17 24.18 25.19 26.19 27.20 28 27.21 29.22 30.23 31.24 32.24 2009 1210 5 SA SA AV 1 EBME(ECG)12 6 4 60 100 2 University of Hawai Carolina Heart&Leg Center 2009 1210 6 100/60/3 20 60 20()2009 1210 7 4 2021 67 SkyQuest Technology Consulting 2028 123 CAGR 9.1%2021 35.0%28.7%60%5 2028 123 6 2021 SkyQuest Technology Consulting Fortune Business Insights Future Market Insights TBInsights SkyQuest Technology Consulting 2020 327.3 0.23%2024 348.3 2020 1159.6 0.80%2024 1260.2 2020/1159.6/327.3/8.2/9.9 0.71%/3.03%2009 1210 8 7 Zengwu Wang The Disease Burden of Atrial Fibrillation in China from a National Cross-sectional Survey 8 9 3 70%60%80%-95%2009 1210 9 10 11 2015-2021 32.8%2021-2024 37.6%2020 58.8%21.4%3.1%2.7%12 2024 211 13 2019/2020/2009 1210 10 14 Mayo Clinic X X 2015/2020 7.1/16.4 1.5/4.3 2024 22.6 15 X/2009 1210 11 X X X+()+2009 1210 12 16+CN114795183A Nick Kelland Advances in 3D Electro anatomical Mapping Systems Young-Hoon Kim 2019 APHRS expert consensus statement 300 CFAE 300 1 2009 1210 13 17 St.Jude Medical+CARTO3 EnSite 2020 90%Columbus HT Viewer+1mm 18 CARTO3 EnSite Precision Rhythmia HDx Columbus HT Viewer 3Ding+1mm 1mm=1mm 1mm 1mm-FAM;CONFIDENSE;AI,;FTI,;RTM;CT/MRI,;,CT MRI/2009 1210 14 3 2022 10 22 19 0 OCTARAY Advisor HD Grid Orion EasyStars 48 TRUEref CARTO 3 16 HD 64 0.02mV 20 NMPA 2023 2020 2015 2022&NMPA 2009 1210 15 20 6 AS Manolis Radiofrequency Catheter Ablation for Cardiac Tachyarrhythmias 375kHz 500kHz 2009 1210 16 21 Michael Barkagan Expandable Lattice Electrode Ablation Catheter 22 Oklahoma Heart Institute Clubafib 2009 1210 17/Pulsed electric fields for cardiac ablation and beyond:A state-of-the-art review/23 Fred H.M.Electroporation and its Relevance for Cardiac Catheter Ablation E Maor Pulsed electric fields for cardiac ablation and beyond:A state-of-the-art review Vivek Y.Reddy Pulsed Field Ablation in Patients With Persistent Atrial Fibrillation 2009 1210 18 24 RVOT-VAS 2023 3 2023 LEAD-PFA PFA NMPA 2023 2 2022 12 FireMagicTrueForce NMPA FireMagicTrueForce 2023 3 1 2009 1210 19 25-NMPA&BCG 2020 89%26 11.6%11.4%10.2%9.5%9.0%9.6%88.4%88.6%89.8%90.5%91.0%90.4%0%20%40%60%80%100%2015 2016 2017 2018 2019 2020 2009 1210 20 27 NMP A 2022 2022 10 14 1 27 12 23 13 2023 4 2 27 18 2273 70 11+30%50%49%15 2009 1210 21 28 27 7.6 8-10 4.2 2023 4 Biosense Webster CARTO 3 Biosense Webster 1510910 1096 634321 143 32 21 1 1 13 310246810121416()()()2009 1210 22 CARTO 3 Abbot EnSite Precision EnSite EnSite CARTO 3 Medtronic NMPA Boston Scientific Faraulse FARAPULSE CE NMPA 29 1944 1929 1977 1992 Biosense Webster Abbot Medtronic Boston Scientific CARTO 3 Ensite FY21 270.60 143.67 118.75 FY21 23.28 19.07 3.65 FY21 20.85%27.18%-+-&NMP A 2009 1210 23 30 CARTO3 EnSite Precision-Rhythmia HDx FDA 2009 2016-2018 NMPA 2014 2019-2018 OCTARAY Advisor HD Grid-Orion FDA 2020 2018-2015 NMPA 2023 2020-2015 QDOT Micro TactiCath-FDA 2022 2014-NMPA 2022 2016-Arctic Front-FDA-2010-NMPA-2016-NMPA NMPA NMPA FARAPULSE CE-2021 NMPA-NMPA FDA&21 HT-Viewer 2022 HT-Viewer 130 6.5%Columbus EasyFinder3D FireMagic 3D 2022 10 2022 12 FireMagicTrueForce 2013 3Ding LEAD-PFA NMPA 2009 1210 24 2021 800 FDA CE PMDA 31 2021 2022 HT-Viewer Triguy Columbus 3Ding AquaSense FY21 8.22 1.90 0.44 FY21 2.33 1.90 FY21 46.38%34.50%FY22 12.04 2.60 FY22 2.93 2.60 FY22 25.92%36.99%-+-&NMP A BCG Wind 32 Columbus HT Viewer 3Ding-NMPA 2016 2021 2013-EasyStars-NMPA 2022-FireMagic-NMPA 2022-NMPA-NMPA-NMPA NMPA-NMPA-NMPA FDA&2009 1210 25 1 2 3 2009 1210 26 2020 2020 2020 2020 2020 2020 2020 2023 2021 2022 2022 2022 2009 1210 27 010-63214682 010-63214682 010-63214682 010-63214682 010-63214682 010-63214682 010-66500808 010-66500821 010-63214682 0755-82828570 0755-83715428 0755-82756804 0755-82871425 0755-83024576 0755-82871425 021-20572536 021-20572555 021-20572257-2552 021-20572506 021-20572585 021-20572560 021-20572509 021-20572548 021-20572573 0755-82756805 021-20572559 021-20572559 0755-82756805 021-20572559 玙 021-25072549 2009 1210 28(300)6 20%6 10%20%6-10%10%6 10%20%3-6 5%3-6-5%5%3-6 5%26 C 3A 1061 A 19 33 12 100033 518034 200120 010-66500801 0755-82027731 021-20572500 010-66500900 0755-82828562 021-20572522
